ALPHATON CAPITAL CORP. (NASDAQ: ATON)

ALPHATON CAPITAL CORP.

NASDAQ: ATON (AlphaTON Capital Corp.)

Last update: 22 hours ago

0.902

0.15 (20.18%)

Add to watchlist

Previous Close	0.750
Open	0.957
Volume	42,973,064
Avg. Volume (3M)	5,161,490
Market Cap	12,005,765

Price / Book

1.04

52 Weeks Range	0.558 (-38%) — 15.82 (1654%)
Earnings Date	13 Apr 2026

AIStockmoo Score

0.3

Analyst Consensus	0.0
Insider Activity	NA
Price Volatility	0.5
Technical Moving Averages	2.5
Technical Oscillators	-2.0
Average	0.25

Ownership

Name	Date	Shares Held
Qtr Family Wealth, Llc	30 Sep 2025	19,272
Princeton Global Asset Management Llc	30 Sep 2025	8
Credit Agricole S A	30 Sep 2025	0
Cwm, Llc	30 Sep 2025	0

No data within this time range.

Date	Type	Details
20 Jan 2026	Announcement	AlphaTON Capital Signs Definitive Agreement to Launch First Fully Privacy-Preserving AI Agents to Telegram’s Billion Users
15 Jan 2026	Announcement	AlphaTON Capital Corp Announces Closing of $15 Million Registered Direct Offering of Ordinary Shares
13 Jan 2026	Announcement	AlphaTON Capital Corp Announces $15 Million Registered Direct Offering
12 Jan 2026	Announcement	AlphaTON Capital Closes $46M AI Infrastructure Expansion to Address Significant Market Demands for Confidential Compute
17 Dec 2025	Announcement	AlphaTON Capital Corp Issues Clarification on Anduril Industries Investment Program
17 Dec 2025	Announcement	AlphaTON Capital Corp Announces Intention to Launch Decentralized AI-Native Biotech Platform Focused on Rare Cancers
16 Dec 2025	Announcement	AlphaTON Capital Strategic Investment in Alpha Liquid Terminal Unveils "The Financial Terminal for the Telegram Economy"
16 Dec 2025	Announcement	AlphaTON Capital Corp Announces Historic Strategic $30 Million Investment in Anduril Industries
15 Dec 2025	Announcement	AlphaTON Capital Secures First NVIDIA B300 Chips with Supermicro HGX Systems
11 Dec 2025	Announcement	AlphaTON Capital Corp Announces First Major Data Center Agreement with atNorth, Securing 2.2 MW of High-Performance Computing Capacity in Sweden
09 Dec 2025	Announcement	AlphaTON Capital World Tour Lands at Abu Dhabi Finance Week
08 Dec 2025	Announcement	AlphaTON Capital Deploys First H200 GPUs on Cocoon AI Network, Launches Revolutionary #OwnYourNode Program to Democratize AI Infrastructure Ownership
05 Dec 2025	Announcement	AlphaTON Capital to Reveal 2026 Technical Strategy in Landmark Inaugural AMA Event
05 Dec 2025	Announcement	AlphaTON Capital to Reveal 2026 Technical Strategy in Landmark Inaugural AMA Event
04 Dec 2025	Announcement	AlphaTON Capital Exits SEC “Baby-Shelf Rules” and Files $420.69 Million Shelf Registration Statement
01 Dec 2025	Announcement	AlphaTON Capital Successfully Deploys First Fleet of Nvidia B200 GPUs to Telegram's Cocoon AI Network, Powering Privacy-First AI for One Billion Users
26 Nov 2025	Announcement	AlphaTON Capital Secures $82.5 Million Strategic GPU Infrastructure to Power Privacy-First Decentralized Artificial Intelligence Cluster after Successful Pilot Launch of Telegram’s Cocoon AI
26 Nov 2025	Announcement	AlphaTON Capital Announces $82.5 Million Strategic GPU Infrastructure Investment to Power Privacy-First Decentralized AI after Successful Pilot Launch of Telegram’s Cocoon AI
25 Nov 2025	Announcement	AlphaTON Capital Corp. to Accumulate Telegram Bonds for its Treasury
24 Nov 2025	Announcement	AlphaTON Capital Submits Strategic Offer to Acquire Majority Stake in Forbes Media Holdings
20 Nov 2025	Announcement	AlphaTON Bolsters Tech Leadership with New CTO to Drive AI Growth
20 Nov 2025	Announcement	AlphaTON Capital (Nasdaq: ATON) Issues Shareholder Update on Balance Sheet Assets and Strategic Ecosystem Expansion Clarification and Correction
19 Nov 2025	Announcement	AlphaTON Capital (Nasdaq: ATON) Issues Shareholder Update on Balance Sheet Assets and Strategic Ecosystem Expansion
17 Nov 2025	Announcement	AlphaTON Capital Names P2P.org as Institutional Staking Partner to Accelerate TON Treasury Yield Strategy
17 Nov 2025	Announcement	AlphaTON Capital Selects P2P.org as First Institutional Staking Partner for TON Treasury Operations
13 Nov 2025	Announcement	AlphaTON Capital and SingularityNET Join Forces to Accelerate Telegram’s Cocoon AI – Growing the Ethical, Decentralized AI Ecosystem
12 Nov 2025	Announcement	AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans
11 Nov 2025	Announcement	AlphaTON Capital Accelerates Global Growth with Strategic Appointment of William De’Ath as Chief Partnership Officer
11 Nov 2025	Announcement	AlphaTON Capital Accelerates Global Growth with Strategic Appointment of William De’Ath as Chief Partnership Officer
07 Nov 2025	Announcement	Complete Tumor Regressions Observed in Preclinical Models with Co-administration of Cyncado’s A2B and A2A Receptor Antagonists and Cancer Vaccines
05 Nov 2025	Announcement	AlphaTON Capital to Acquire Premier Crypto Newswire Blockchain Wire, Cementing Dominance in Digital Asset Communications via the Telegram Ecosystem
04 Nov 2025	Announcement	DAT ALERT: AlphaTON Capital Acquires 300,000 additional TON
03 Nov 2025	Announcement	AlphaTON Capital Corp Announces Strategic Joint Venture with Pago Pay and with ALT5 Sigma to Launch Crypto-Enabled TON Mastercard
03 Nov 2025	Announcement	Brittany Kaiser to Present at SALT London 2025 on DeFi, Tokenization, and Digital Asset Treasuries
03 Nov 2025	Announcement	AlphaTON Capital Takes Center Stage at TRUST Summit 2025 to Shape the Future of Digital Finance
31 Oct 2025	Announcement	AlphaTON Capital Kicks Off Global World Tour with Investor Breakfast at Nasdaq MarketSite
29 Oct 2025	Announcement	AlphaTON Capital Announces Strategic Investment in GPU Infrastructure to Power Cocoon Decentralized AI Network
27 Oct 2025	Announcement	AlphaTON Capital CEO Brittany Kaiser to Speak at “Future of Money, Governance, and the Law” Summit on Capitol Hill, October 30, 2025
27 Oct 2025	Announcement	AlphaTON (Nasdaq:ATON) and Cyncado Therapeutics: Preclinical Mesothelioma Data Show Direct A2B Tumor Activity; TT-4 Achieved >90% Tumor Growth Inhibition; First-Patient Dosing on Track for Q1 2026
25 Oct 2025	Announcement	AlphaTON Capital and Cyncado Therapeutics Share New Mesothelioma Data Supporting TT-4’s Path to First- Patient Dosing
24 Oct 2025	Announcement	AlphaTON Capital Appoints Wes Levitt as Chief Financial Officer
22 Oct 2025	Announcement	AlphaTON Capital Joins Blockchain Game Alliance (BGA)
22 Oct 2025	Announcement	AACR Abstract: First Evidence that Selective A2B Receptor Inhibition Lowers PD-L1 Tumor Expression and also Directly Suppresses Mesothelioma Tumor Growth
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Realized Profit	-
Unrealized Profit	-
Dividend Received 2026	-
Total Profit	-
Avg. Return	-
Quantity (Buy)	-
Avg. Price (Buy)	-
Quantity (Sold)	-
Avg. Price (Sold)	-

No stocks matching your criteria

Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)